Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.6 USD | -1.10% | +0.88% | +44.87% |
08/05 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
19/03 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.87% | 2.1B | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug